Onyx Pharmaceuticals Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Employees
-
741
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$9.7B
Onyx Pharmaceuticals General Information
Description
Developer of drugs to treat cancer. The company is engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer.
Contact Information
Website
onyx-pharm.comCorporate Office
- 249 East Grand Avenue
- South San Francisco, CA 94080
- United States
Corporate Office
- 249 East Grand Avenue
- South San Francisco, CA 94080
- United States
Onyx Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 01-Oct-2013 | $9.7B | Completed | Generating Revenue | ||
| 11. PIPE | 29-Sep-2006 | Completed | Generating Revenue | |||
| 10. PIPE | 01-Dec-2005 | Completed | Generating Revenue | |||
| 9. PIPE | 25-Feb-2003 | Completed | Generating Revenue | |||
| 8. 2PO | 13-Jun-2002 | Completed | Generating Revenue | |||
| 7. PIPE | 17-May-2002 | Completed | Generating Revenue | |||
| 6. PIPE | 10-May-2002 | Completed | Generating Revenue | |||
| 5. PIPE | 20-Jan-2000 | Completed | Generating Revenue | |||
| 4. PIPE | 01-Oct-1999 | $8M | $59.2M | Completed | Generating Revenue | |
| 3. IPO | 09-May-1996 | $30M | $51.2M | Completed | Generating Revenue |
Onyx Pharmaceuticals Comparisons
Industry
Financing
Details
Onyx Pharmaceuticals Competitors (21)
One of Onyx Pharmaceuticals’s 21 competitors is Agios Pharmaceuticals, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agios Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Ardelyx | Formerly VC-backed | Waltham, MA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| CSL Behring | Corporation | King Of Prussia, PA |
Onyx Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Onyx Pharmaceuticals Patents
Onyx Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023309181-A1 | Methods of treating multiple myeloma using bcl-2 inhibitor | Pending | 21-Jul-2022 | ||
| EP-4558143-A1 | Methods of treating multiple myeloma using bcl-2 inhibitor | Pending | 21-Jul-2022 | ||
| EP-4558143-A4 | Methods of treating multiple myeloma using bcl-2 inhibitor | Pending | 21-Jul-2022 | ||
| US-20250161279-A1 | Methods of treating multiple myeloma using bcl-2 inhibitor | Pending | 21-Jul-2022 | ||
| US-12636340-B2 | Methods of treating multiple myeloma | Active | 29-Apr-2020 | A61K38/07 |
Onyx Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Onyx Pharmaceuticals Former Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alta Partners | Venture Capital | Minority | ||
| Avalon Ventures | Venture Capital | Minority | ||
| Bayer Schering Pharma | Corporation | Minority | ||
| Chase Capital Partners | PE/Buyout | Minority | ||
| Chiron (Biotechnology) | Corporation | Minority |
Onyx Pharmaceuticals Investments & Acquisitions (4)
Onyx Pharmaceuticals’s most recent deal was a Early Stage VC with Kezar Life Sciences for . The deal was made on 25-Jul-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kezar Life Sciences | 25-Jul-2017 | Early Stage VC | Drug Discovery | ||
| Proteolix | 12-Oct-2009 | Merger/Acquisition | Drug Discovery | ||
| S*BIO | 06-Jan-2009 | Later Stage VC | Pharmaceuticals | ||
| Syrrx | 10-Jan-2003 | Early Stage VC | Drug Discovery |
Onyx Pharmaceuticals FAQs
-
When was Onyx Pharmaceuticals founded?
Onyx Pharmaceuticals was founded in 1992.
-
Where is Onyx Pharmaceuticals headquartered?
Onyx Pharmaceuticals is headquartered in South San Francisco, CA.
-
What is the size of Onyx Pharmaceuticals?
Onyx Pharmaceuticals has 741 total employees.
-
What industry is Onyx Pharmaceuticals in?
Onyx Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Onyx Pharmaceuticals a private or public company?
Onyx Pharmaceuticals is a Private company.
-
What is the current valuation of Onyx Pharmaceuticals?
The current valuation of Onyx Pharmaceuticals is .
-
What is Onyx Pharmaceuticals’s current revenue?
The current revenue for Onyx Pharmaceuticals is .
-
How much funding has Onyx Pharmaceuticals raised over time?
Onyx Pharmaceuticals has raised $300M.
-
Who are Onyx Pharmaceuticals’s investors?
Alta Partners, Avalon Ventures, Bayer Schering Pharma, Chase Capital Partners, and Chiron (Biotechnology) are 5 of 23 investors who have invested in Onyx Pharmaceuticals.
-
Who are Onyx Pharmaceuticals’s competitors?
Agios Pharmaceuticals, Inovio Pharmaceuticals, Ardelyx, Bristol-Myers Squibb, and CSL Behring are some of the 21 competitors of Onyx Pharmaceuticals.
-
When was Onyx Pharmaceuticals acquired?
Onyx Pharmaceuticals was acquired on 01-Oct-2013.
-
Who acquired Onyx Pharmaceuticals?
Onyx Pharmaceuticals was acquired by Amgen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
